stomach pain with glp 1 Managing common side effects of GLP-1 medications Support for Patients on GLP-1

Experts recommend consuming about 1.6 grams of protein per kilogram of body weight per day

Nirmatrelvir and risk of hospital admission or death in adults with Covid-19: emulation of a randomized target trial using electronic health records

According to the FDA prescribing information, nausea, diarrhea, and vomiting are among the most common side effects, with rates varying by dose

( PMID: 23324757 ) Benzaquen M, Borradori L, Berbis P, Cazzaniga S, Valero R, Richard MA, Feldmeyer L (2018) Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland

A weight-loss drug that could be relevant to a large share of the workforce is another

Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)